Clinical Trials Directory

Trials / Completed

CompletedNCT06016543

Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms

Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms - A Pilot Prospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
7 (actual)
Sponsor
A.T. Still University of Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to determine the feasibility of conducting a large-scale study on the effect of using osteopathic manipulative treatment (OMT) to treat patients with post-COVID-19 symptoms. The main questions it aims to answer are: 1. Is it feasible to conduct a large-scale study of the effect of OMT on patients with post-COVID-19 symptoms (based on how many patients agree to participate and how many complete the study)? 2. How much change in patients' post-COVID-19 symptom severity, quality of life, and ability to return to work can we expect to see following OMT? Participants will receive OMT as directed by their physician and complete questionnaires after every other OMT session. 1. Participants will complete questionnaires about their post-COVID-19 symptoms, quality of life, ability to return to work, and adverse events they experienced 3 days after every other OMT session. 2. Participants will be sent links to the questionnaires for 4 months or when their symptoms resolve, whichever comes first. 3. Additionally, participants will complete a follow-up questionnaire 2 months after they stop receiving OMT for their post-COVID-19 symptoms or 6 months after enrollment in the study, whichever comes first.

Conditions

Interventions

TypeNameDescription
PROCEDUREosteopathic manipulative treatment (OMT)Osteopathic manipulative treatment provided at the discretion of the treating physician and based on the patient's response to previous treatments.

Timeline

Start date
2023-09-18
Primary completion
2024-07-10
Completion
2024-07-10
First posted
2023-08-29
Last updated
2024-07-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06016543. Inclusion in this directory is not an endorsement.